Kisspeptin-10 (KISS10)

Sexual Health Clinical trials

Fragment of kisspeptin that stimulates GnRH release, playing a key role in puberty initiation and reproductive function.

Key Data

Research Status
Clinical trials
Half-Life
~28 minutes
Administration
Subcutaneous or IV injection
Typical Dosage
1-10 mcg/kg

Mechanism of Action

Activates GnRH neurons to stimulate pituitary release of LH and FSH.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home